ALFA News
Straight from the exchange filing
Every announcement Gland Pharma has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Gland Pharma announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Gland Pharma signs a strategic CDMO partnership with a global pharmaceutical company for sterile injectables, projecting an annualized revenue of ₹902.5 Crore.
Gland Pharma launches USFDA-approved Sugammadex Injection vials, targeting a USD 1.6 billion US market for the reversal of surgical neuromuscular blockade now.
